Wednesday, August 29, 2018

Laurus Labs gets USFDA nod for diabetes drug

Laurus Labs gets USFDA nod for diabetes drug The company has received approval from United States Food and Drug Administration (USFDA) for Metformin hydrochloride tablets USP in the strengths of 500 mg, 850 mg and 1,000 mg, Laurus Labs said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2wr8041
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...